Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments

BACKGROUND: Peripheral blood-based biomarkers (PBB) predicting response, survival and immune-related adverse events (irAEs) in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) are still a matter of debate. Thus, we investigated the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuequan, Liu, Xiaoyan, Liu, Jia, Zhang, Dongming, Liu, Xiangning, Yue, Yuan, Zhou, Qing, Gao, Xiaoxing, Chen, Minjiang, Xu, Yan, Zhao, Jing, Zhong, Wei, Provencio, Mariano, Jassem, Jacek, Williams, Terence M., Seeber, Andreas, Kocher, Florian, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743518/
https://www.ncbi.nlm.nih.gov/pubmed/35070755
http://dx.doi.org/10.21037/tlcr-21-710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743518/
https://www.ncbi.nlm.nih.gov/pubmed/35070755
http://dx.doi.org/10.21037/tlcr-21-710

Ejemplares similares